Towards a treatment for genetic prion disease: trials and biomarkers

SM Vallabh, EV Minikel, SL Schreiber… - The Lancet …, 2020 - thelancet.com
Prion disease is a rare, fatal, and exceptionally rapid neurodegenerative disease. Although
incurable, prion disease follows a clear pathogenic mechanism, in which a single gene …

Prion therapeutics: Lessons from the past

KH Shim, N Sharma, SSA An - Prion, 2022 - Taylor & Francis
Prion diseases are a group of incurable zoonotic neurodegenerative diseases (NDDs) in
humans and other animals caused by the prion proteins. The abnormal folding and …

Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints

EV Minikel, HT Zhao, J Le, J O'Moore… - Nucleic acids …, 2020 - academic.oup.com
Lowering of prion protein (PrP) expression in the brain is a genetically validated therapeutic
hypothesis in prion disease. We recently showed that antisense oligonucleotide (ASO) …

Structural heterogeneity and intersubject variability of Aβ in familial and sporadic Alzheimer's disease

C Condello, T Lemmin, J Stöhr… - Proceedings of the …, 2018 - National Acad Sciences
Point mutations in the amyloid-β (Aβ) coding region produce a combination of mutant and
WT Aβ isoforms that yield unique clinicopathologies in familial Alzheimer's disease (fAD) …

[HTML][HTML] Antisense oligonucleotides extend survival of prion-infected mice

GJ Raymond, HT Zhao, B Race, LD Raymond… - JCI insight, 2019 - ncbi.nlm.nih.gov
Prion disease is a fatal, incurable neurodegenerative disease of humans and other
mammals caused by conversion of cellular prion protein (PrP C) into a self-propagating …

Human stem cell–derived astrocytes replicate human prions in a PRNP genotype–dependent manner

Z Krejciova, J Alibhai, C Zhao, R Krencik… - Journal of Experimental …, 2017 - rupress.org
Prions are infectious agents that cause neurodegenerative diseases such as Creutzfeldt–
Jakob disease (CJD). The absence of a human cell culture model that replicates human …

Age at onset in genetic prion disease and the design of preventive clinical trials

EV Minikel, SM Vallabh, MC Orseth, JP Brandel… - Neurology, 2019 - AAN Enterprises
Objective To determine whether preventive trials in genetic prion disease could be designed
to follow presymptomatic mutation carriers to onset of disease. Methods We assembled age …

Cellular models for discovering prion disease therapeutics: Progress and challenges

SH Krance, R Luke, M Shenouda… - Journal of …, 2020 - Wiley Online Library
Prions, which cause fatal neurodegenerative disorders such as Creutzfeldt‐Jakob disease,
are misfolded and infectious protein aggregates. Currently, there are no treatments available …

Therapeutic trial of anle138b in mouse models of genetic prion disease

SM Vallabh, D Zou, R Pitstick, J O'Moore… - Journal of …, 2023 - Am Soc Microbiol
Phenotypic screening has yielded small-molecule inhibitors of prion replication that are
effective in vivo against certain prion strains but not others. Here, we sought to test the small …

Evidence for preexisting prion substrain diversity in a biologically cloned prion strain

T Gunnels, RA Shikiya, TC York, AJ Block… - PLoS …, 2023 - journals.plos.org
Prion diseases are a group of inevitably fatal neurodegenerative disorders affecting
numerous mammalian species, including Sapiens. Prions are composed of PrPSc, the …